Medications

FDA delays decision on new Alzheimer's drug

Instead of approving the new Alzheimer's drug donanemab this month, as was expected, the U.S. Food and Drug Administration will now require the experimental medication be scrutinized more closely by an expert panel, the drug's ...

Alzheimer's disease & dementia

Highly awaited Alzheimer's drug hit by delays

Eli Lilly's highly anticipated Alzheimer's drug has been held back for further review by regulators, the US pharmaceutical giant said Friday, in a blow for patients with the devastating brain disorder.

Alzheimer's disease & dementia

Do you really want to find out if you'll get Alzheimer's?

A few years ago, researchers made the unnerving discovery that in the brains of people with Alzheimer's disease, disordered clumps of abnormal proteins had been growing for 15 or even 20 years before their diagnosis. That ...

Neuroscience

People with essential tremor may have increased risk of dementia

Dementia may be three times more common among people with essential tremor, a movement disorder that causes involuntary shaking, than the general population, according to research released today, March 6, 2024. The study ...

Alzheimer's disease & dementia

Social determinants of health increase Alzheimer's risk

Social determinants of health are increasing the risk of Alzheimer's disease and related dementia, finds a recent study from the Brown School and the School of Medicine at Washington University in St. Louis.

page 9 from 543